PCYT2 and Disorder of lipid metabolism: Targeted quantitative lipidomics studies confirmed a pathogenic role for variants in genes associated with lipid metabolism disorders, such as PI4KA [38], PCYT2 [40] and ACER3, in n = 4 cases.